- Home
- INDV vs SYRE Comparison
INDV vs SYRE Comparison
Compare INDV & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDV
- SYRE
- Stock Information
- Founded
- INDV 1994
- SYRE 2013
- Country
- INDV United States
- SYRE United States
- Employees
- INDV N/A
- SYRE 60
- Industry
- INDV Biotechnology: Pharmaceutical Preparations
- SYRE Biotechnology: Pharmaceutical Preparations
- Sector
- INDV Health Care
- SYRE Health Care
- Exchange
- INDV Nasdaq
- SYRE Nasdaq
- Market Cap
- INDV 1.2B
- SYRE 1.3B
- IPO Year
- INDV N/A
- SYRE 2016
- Fundamental
- Price
- INDV $8.45
- SYRE $21.29
- Analyst Decision
- INDV Strong Buy
- SYRE Strong Buy
- Analyst Count
- INDV 2
- SYRE 8
- Target Price
- INDV $16.00
- SYRE $51.50
- AVG Volume (30 Days)
- INDV 1.2M
- SYRE 550.7K
- Earning Date
- INDV 02-20-2025
- SYRE 03-03-2025
- Dividend Yield
- INDV N/A
- SYRE N/A
- EPS Growth
- INDV N/A
- SYRE N/A
- EPS
- INDV N/A
- SYRE N/A
- Revenue
- INDV $1,188,000,000.00
- SYRE N/A
- Revenue This Year
- INDV $6.59
- SYRE $168.62
- Revenue Next Year
- INDV N/A
- SYRE $47.61
- P/E Ratio
- INDV N/A
- SYRE N/A
- Revenue Growth
- INDV 8.69
- SYRE N/A
- 52 Week Low
- INDV $7.33
- SYRE $20.13
- 52 Week High
- INDV $23.22
- SYRE $47.97
- Technical
- Relative Strength Index (RSI)
- INDV 30.24
- SYRE 40.66
- Support Level
- INDV $9.74
- SYRE $21.61
- Resistance Level
- INDV $11.27
- SYRE $23.04
- Average True Range (ATR)
- INDV 0.51
- SYRE 1.43
- MACD
- INDV -0.18
- SYRE -0.03
- Stochastic Oscillator
- INDV 2.01
- SYRE 22.03
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. A range of pharmaceutical options to address IBD exists, including anti-inflammatory drugs, immunosuppressants, and biologics.